RECRUITING

Exercise Intervention in Adolescent and Young Adult Cancer Survivors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Adolescent and young adult (AYA) survivors of cancer face a future of persistent medical issues across a wide spectrum of diseases One study examining health data from this cohort (ages 15-29) reported significantly higher rates of smoking, obesity, cardiovascular disease, hypertension, asthma, and poorer mental health among the cancer survivors when compared to healthy controls. Prescribed exercise has broad and far-reaching beneficial physiological effects that cut across multiple body systems and consistently improves emotional well-being, decreases fatigue and depression, and enhances quality of life. Although a growing body of evidence consistently demonstrates the physiological and psychological benefits of exercise interventions in adults with cancer, there are no studies examining the effects of individualized, prescribed, supervised exercise in pediatric, adolescent and young adult cancer survivors.

Official Title

One-on-one Exercise Program in Adolescent and Young Adult Cancer Survivors With a Certified Clinical Cancer Exercise Specialist

Quick Facts

Study Start:2019-06-05
Study Completion:2024-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04265638

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:15 Years to 39 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age ≥ 15 and ≤ 39 years,
  2. 2. History of cancer
  3. 3. At least three months off of cytotoxic chemotherapy (note: hormone therapy is permitted)
  1. 1. Evidence of significant liver dysfunction, congestive heart failure, cardiovascular disease
  2. 2. History of CNS tumor
  3. 3. Down's Syndrome
  4. 4. Unable to perform aerobic and/or strength exercises with full range of motion (limb immobilization, limb amputation, or surgical complications.
  5. 5. Neurological disorder
  6. 6. Baseline exercise of 30 minutes per day three times a week already being performed.

Contacts and Locations

Study Contact

NiCole Keith, PhD
CONTACT
317-278-8438
nkeith@iupui.edu

Study Locations (Sites)

IU Health North Hospital
Carmel, Indiana, 46032
United States
Riley Hospital for Children - Indiana University
Indianapolis, Indiana, 46202
United States
Indianapolis Healthplex
Indianapolis, Indiana, 46222
United States

Collaborators and Investigators

Sponsor: Indiana University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-06-05
Study Completion Date2024-05

Study Record Updates

Study Start Date2019-06-05
Study Completion Date2024-05

Terms related to this study

Additional Relevant MeSH Terms

  • Long-term Effects Secondary to Cancer Therapy in Adults
  • Pediatric Cancer